Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
6.11
+0.01 (0.19%)
Sep 1, 2026, 3:04 PM EDT - Market open
Aardvark Therapeutics Market Cap
Aardvark Therapeutics has a market cap or net worth of $133.75 million as of September 1, 2026. Its market cap has decreased by -25.73% in one year.
Market Cap
133.75M
Enterprise Value
60.55M
1-Year Change
-25.73%
Ranking
Category
Stock Price
$6.11
ChartMarket Cap Chart
Since the IPO on February 13, 2025, Aardvark Therapeutics's market cap has decreased from $342.15M to $133.75M, a decrease of -60.91%. That is a compound annual growth rate of -45.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 133.75M | -53.20% |
| Dec 31, 2025 | 285.77M | -16.48% |
| Feb 13, 2025 | 342.15M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TuHURA Biosciences | 134.46M |
| Inovio Pharmaceuticals | 133.38M |
| Tiziana Life Sciences | 130.60M |
| Black Diamond Therapeutics | 128.12M |
| Vivani Medical | 128.09M |
| Cibus | 126.11M |
| Biomea Fusion | 125.40M |
| ProMIS Neurosciences | 123.62M |